Abaxis (Abaxis) Ending Cash Position : $46.3 Mil (As of Mar. 2018)

View and export this data going back to 1992. Start your Free Trial

What is Abaxis Ending Cash Position?

Abaxis's Ending Cash Position for the quarter that ended in Mar. 2018 was $46.3 Mil.

Abaxis's quarterly Ending Cash Position increased from Sep. 2017 ($58.9 Mil) to Dec. 2017 ($71.9 Mil) but then declined from Dec. 2017 ($71.9 Mil) to Mar. 2018 ($46.3 Mil).

Abaxis's annual Ending Cash Position increased from Mar. 2016 ($88.3 Mil) to Mar. 2017 ($91.3 Mil) but then declined from Mar. 2017 ($91.3 Mil) to Mar. 2018 ($46.3 Mil).

Abaxis Ending Cash Position Historical Data

The historical data trend for Abaxis's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Ending Cash Position Chart

Abaxis Annual Data

Trend

Mar09

Mar10

Mar11

Mar12

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Ending Cash Position

Get a 7-Day Free Trial

73.59

107.02

88.32

91.33

46.28

Abaxis Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
Ending Cash Position	Get a 7-Day Free Trial															91.33	91.47	58.87	71.90	46.28

Abaxis Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Abaxis's Ending Cash Position for the fiscal year that ended in Mar. 2018 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	92.399	+	-46.122
	=	46.3

Abaxis's Ending Cash Position for the quarter that ended in Mar. 2018 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	72.054	+	-25.777
	=	46.3

Abaxis Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Abaxis's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Abaxis (Abaxis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.abaxis.com

Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.

Executives

Richard Bastiani	director	C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr	officer: CFO and VP of Finance	C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson	director, officer: CEO & Board Chairman	C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey	director	ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020